The breakpoint cluster region-Abelson (BCR-ABL) is the cytoplasmic fusion oncoprotein with constitutive tyrosine kinase activity, associated with Philadelphia chromosome responsible for acute lymphoblastic and chronic myeloid leukemias [1]–[4]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.